The current valuation score of Geron Corp is 7.81, ranking 179 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -14.37, which is -100.00% below the recent high of 0.00 and -14.00% above the recent low of -16.38.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.